The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Amantadine hydrochloride, Symmetrel Drug Master File in Japan (Amantadine hydrochloride, Symmetrel JDMF) empowers Amantadine hydrochloride, Symmetrel API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Amantadine hydrochloride, Symmetrel JDMF during the approval evaluation for pharmaceutical products. At the time of Amantadine hydrochloride, Symmetrel JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Amantadine hydrochloride, Symmetrel suppliers with JDMF on PharmaCompass.